NexGel (NASDAQ:NXGL – Get Free Report) posted its quarterly earnings data on Saturday. The company reported ($2.28) earnings per share for the quarter, topping the consensus estimate of ($4.80) by $2.52, FiscalAI reports. The firm had revenue of $3.18 million during the quarter, compared to analyst estimates of $4.19 million. NexGel had a negative return on equity of 121.18% and a negative net margin of 51.26%.
NexGel Stock Performance
NASDAQ:NXGL opened at $3.88 on Monday. NexGel has a 12 month low of $3.00 and a 12 month high of $41.20. The company has a current ratio of 0.43, a quick ratio of 0.27 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $1.90 million, a price-to-earnings ratio of -0.27 and a beta of 0.81. The firm has a fifty day simple moving average of $4.51 and a two-hundred day simple moving average of $11.31.
Insider Activity
In related news, CEO Brian Joseph Kieser acquired 133,216 shares of the company’s stock in a transaction dated Tuesday, November 10th. The shares were purchased at an average price of $5.50 per share, for a total transaction of $732,688.00. Following the completion of the acquisition, the chief executive officer owned 133,216 shares of the company’s stock, valued at approximately $732,688. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Steven Mark Glassman acquired 4,546 shares of the business’s stock in a transaction dated Tuesday, November 10th. The shares were bought at an average cost of $5.50 per share, for a total transaction of $25,003.00. Following the transaction, the director directly owned 12,379 shares in the company, valued at approximately $68,084.50. This represents a 58.04% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 19.79% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
NXGL has been the topic of several research analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of NexGel in a research report on Friday, October 9th. Zacks Research upgraded NexGel to a “hold” rating in a report on Friday, October 2nd. Finally, Maxim Group downgraded shares of NexGel from a “buy” rating to a “hold” rating in a research report on Monday, August 24th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $40.00.
View Our Latest Analysis on NexGel
About NexGel
NexGel, Inc. (NASDAQ:NXGL) develops and manufactures high-water-content hydrogel products for medical, consumer and other specialized applications. The company uses proprietary formulations and electron-beam processing to produce flexible, skin-compatible products designed to retain moisture and provide cooling, cushioning or conductive properties. Its product applications include wound care, burn and surgical care, pain management, medical diagnostics and personal wellness. NexGel supplies hydrogel sheets, patches and related components used in products such as wound dressings, therapeutic pads and medical electrodes.
Read More
- Five stocks we like better than NexGel
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
